IGF OT IGF MR CONTRAST AGENT TO QUANTIFY MYOCARDIAL FIBROSIS SBIR TOPIC PHASE II
Award amount
$1,040,592Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- COLLAGEN MEDICAL LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- GJLBDQT8K757
- Solicitation number
- Not reported
- Topic code
- DHVD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Theranostic for gastric cancer
- Theranostic for gastric cancer
- PET imaging of radiation induced lung injury
- New class of collagen-targeted contrast agents for Magnetic Resonance Imaging
- Targeted Imaging of Fibrosis in the Left Atrium
Research funding history
20 SBIR/STTR records share this UEI (2012–2024). Reported award amounts total $15,782,674. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services